chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: is a fever normal; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (is a fever normal) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (is a fever normal). At the time of the report, PYREXIA (is a fever normal) outcome was unknown.            No Relevant concomitant medications was reported.  Treatment information was not provided.  Action taken with mRNA-1273 Moderna COVID-19 Vaccine was not applicable
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Symptoms appear after the 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Symptoms appear after the 2nd dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Symptoms appear after the 2nd dose). At the time of the report, VACCINATION COMPLICATION (Symptoms appear after the 2nd dose) outcome was unknown.            Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: Sickness; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sickness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Sickness). At the time of the report, ILLNESS (Sickness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information provided. No  treatment information given.
Sex: U
Vaccine: COVID19
Symptoms: Asthenia, Malaise
Clinical narrative: feeling weak; feeling sick; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (feeling weak) and MALAISE (feeling sick) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (feeling weak) and MALAISE (feeling sick). At the time of the report, ASTHENIA (feeling weak) and MALAISE (feeling sick) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.  No Relevant concomitant medications was reported.  Treatment information was not provided
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance, Pain in extremity
Clinical narrative: sharp pain down the back of my left leg, the next day it was gone; I was limping around, the next day it was gone; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sharp pain down the back of my left leg, the next day it was gone) and GAIT DISTURBANCE (I was limping around, the next day it was gone) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included APIXABAN (ELIQUIS) and OMEPRAZOLE for an unknown indication.    On 06-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2021, the patient experienced PAIN IN EXTREMITY (sharp pain down the back of my left leg, the next day it was gone) and GAIT DISTURBANCE (I was limping around, the next day it was gone). At the time of the report, PAIN IN EXTREMITY (sharp pain down the back of my left leg, the next day it was gone) and GAIT DISTURBANCE (I was limping around, the next day it was gone) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Vaccination site tenderness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (tenderness at injection site for 72 hours) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced VACCINATION SITE PAIN (tenderness at injection site for 72 hours). On 02-May-2021, VACCINATION SITE PAIN (tenderness at injection site for 72 hours) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Reporter answered yes to bot's question that they are having side effect and received Moderna COVID-19 vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Reporter answered yes to bot's question that they are having side effect and received Moderna COVID-19 vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Reporter answered yes to bot's question that they are having side effect and received Moderna COVID-19 vaccine). At the time of the report, VACCINATION COMPLICATION (Reporter answered yes to bot's question that they are having side effect and received Moderna COVID-19 vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information was provided. Treatment information was not provided.    Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Antibody test, Antibody test negative
Clinical narrative: the second antibody test, three months later came back with a negative result below 1; This spontaneous case was reported by a consumer and describes the occurrence of ANTIBODY TEST NEGATIVE (the second antibody test, three months later came back with a negative result below 1) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031IL20A and 027A21A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis since 1997, Hypothyroidism since 1980, Hypertension since 2006, Seizures since 2008, Restless legs since 2010, Penicillin allergy and Shellfish allergy. Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) for Cholesterol, NORTRIPTYLINE HYDROCHLORIDE (NORTRIPTYLINE [NORTRIPTYLINE HYDROCHLORIDE]) for Depression, NEBIVOLOL HYDROCHLORIDE (BYSTOLIC) for Hypertension, LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism, ESTROGENS CONJUGATED (PREMARIN) for Hysterectomy, ROPINIROLE HCL for Restless legs, TOFACITINIB CITRATE (XELJANZ) for Rheumatoid arthritis, LAMOTRIGINE for Seizures, EPINEPHRINE (EPIPEN), PARACETAMOL (TYLENOL), NAPROXEN SODIUM (ALEVE) and ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN MIGRAINE) for an unknown indication.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Oral) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Oral) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ANTIBODY TEST NEGATIVE (the second antibody test, three months later came back with a negative result below 1). At the time of the report, ANTIBODY TEST NEGATIVE (the second antibody test, three months later came back with a negative result below 1) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: 2.94 Positive and (Negative) below 1.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Oral), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 with the event was considered as not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Follow up information received on 01-jul-2021 contains Significant information Added concomitants Synthroid, Premarin, Lipitor, ropinirol HLC, Bystolic, XELJANZ , LAMOTRIGINE,  NORTRIPTYLINE, EPIPEN . Added treatment drugs TYLENOL, ALEVE, EXCEDRIN MIGRAINE. Added medical history Allergy to penicillin , shellfish and rheumatoid arthritis,  hypothyroid, hypertension, restless leg, seizures.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Malaise, Pain in extremity, Pyrexia
Clinical narrative: woke up with a ball on the face at the level of the cheekbone, very very hard, that is turning purple; my arm hurts; tired; my head hurts; fever; feeling indisposed; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feeling indisposed), SKIN MASS (woke up with a ball on the face at the level of the cheekbone, very very hard, that is turning purple), PAIN IN EXTREMITY (my arm hurts), FATIGUE (tired) and HEADACHE (my head hurts) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (aspirin).   On 03-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Jun-2021, the patient experienced MALAISE (feeling indisposed), PAIN IN EXTREMITY (my arm hurts), FATIGUE (tired), HEADACHE (my head hurts) and PYREXIA (fever). On 04-Jun-2021, the patient experienced SKIN MASS (woke up with a ball on the face at the level of the cheekbone, very very hard, that is turning purple). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MALAISE (feeling indisposed), SKIN MASS (woke up with a ball on the face at the level of the cheekbone, very very hard, that is turning purple), PAIN IN EXTREMITY (my arm hurts), FATIGUE (tired), HEADACHE (my head hurts) and PYREXIA (fever) outcome was unknown.            Concomitant medication information was not reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) is considered as not applicable.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Skin mass
Clinical narrative: woke up with a ball on the face at the level of the cheekbone, very very hard, that is turning purple; my arm hurts; tired; my head hurts; fever; feeling indisposed; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feeling indisposed), SKIN MASS (woke up with a ball on the face at the level of the cheekbone, very very hard, that is turning purple), PAIN IN EXTREMITY (my arm hurts), FATIGUE (tired) and HEADACHE (my head hurts) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (aspirin).   On 03-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Jun-2021, the patient experienced MALAISE (feeling indisposed), PAIN IN EXTREMITY (my arm hurts), FATIGUE (tired), HEADACHE (my head hurts) and PYREXIA (fever). On 04-Jun-2021, the patient experienced SKIN MASS (woke up with a ball on the face at the level of the cheekbone, very very hard, that is turning purple). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MALAISE (feeling indisposed), SKIN MASS (woke up with a ball on the face at the level of the cheekbone, very very hard, that is turning purple), PAIN IN EXTREMITY (my arm hurts), FATIGUE (tired), HEADACHE (my head hurts) and PYREXIA (fever) outcome was unknown.            Concomitant medication information was not reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) is considered as not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Sexual dysfunction
Clinical narrative: used to be super good performing in intimacy with my partner; This spontaneous case was reported by a consumer and describes the occurrence of SEXUAL DYSFUNCTION (used to be super good performing in intimacy with my partner) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SEXUAL DYSFUNCTION (used to be super good performing in intimacy with my partner). At the time of the report, SEXUAL DYSFUNCTION (used to be super good performing in intimacy with my partner) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information is not provided.  Concomitant medications were not provided.
Sex: U
Vaccine: COVID19
Symptoms: Feeling abnormal, Haematocrit
Clinical narrative: i still feel weird; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (i still feel weird) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 18-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (i still feel weird). At the time of the report, FEELING ABNORMAL (i still feel weird) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Haematocrit: high (High) High.         The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.  Patient had to have blood thinned because of high hematocrit levels.  No Relevant concomitant medications was reported.  Treatment information was not provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling, Product administration error, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Vaccination site warm; Vaccination site itching 2-3 inches in diameter; Vaccination site swollen 2-3 inches in diameter; Injection site redness 4-5 inches in diameter /Injection site Bright pink/ red in color; Injection site swelling 4-5 inches in diameter; Vaccination site raised 4-5 inches in diameter; Vaccination site hot to the touch; Vaccination site tenderness; Product administration error; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Vaccination site hot to the touch), VACCINATION SITE PAIN (Vaccination site tenderness), PRODUCT ADMINISTRATION ERROR (Product administration error), VACCINATION SITE WARMTH (Vaccination site warm) and VACCINATION SITE REACTION (Vaccination site raised 4-5 inches in diameter) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-May-2021, the patient experienced VACCINATION SITE WARMTH (Vaccination site hot to the touch), VACCINATION SITE PAIN (Vaccination site tenderness), PRODUCT ADMINISTRATION ERROR (Product administration error), VACCINATION SITE REACTION (Vaccination site raised 4-5 inches in diameter), INJECTION SITE ERYTHEMA (Injection site redness 4-5 inches in diameter /Injection site Bright pink/ red in color) and INJECTION SITE SWELLING (Injection site swelling 4-5 inches in diameter). On 04-Jun-2021, the patient experienced VACCINATION SITE WARMTH (Vaccination site warm), VACCINATION SITE PRURITUS (Vaccination site itching 2-3 inches in diameter) and VACCINATION SITE SWELLING (Vaccination site swollen 2-3 inches in diameter). At the time of the report, VACCINATION SITE WARMTH (Vaccination site hot to the touch), VACCINATION SITE PAIN (Vaccination site tenderness), PRODUCT ADMINISTRATION ERROR (Product administration error), VACCINATION SITE WARMTH (Vaccination site warm), VACCINATION SITE REACTION (Vaccination site raised 4-5 inches in diameter), VACCINATION SITE PRURITUS (Vaccination site itching 2-3 inches in diameter), INJECTION SITE ERYTHEMA (Injection site redness 4-5 inches in diameter /Injection site Bright pink/ red in color), INJECTION SITE SWELLING (Injection site swelling 4-5 inches in diameter) and VACCINATION SITE SWELLING (Vaccination site swollen 2-3 inches in diameter) outcome was unknown.            Action taken with mRNA-1273 in response to the event were not applicable. Treatment information was not provided Concomitant medication were not provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Vaccination site warm; Vaccination site itching 2-3 inches in diameter; Vaccination site swollen 2-3 inches in diameter; Injection site redness 4-5 inches in diameter /Injection site Bright pink/ red in color; Injection site swelling 4-5 inches in diameter; Vaccination site raised 4-5 inches in diameter; Vaccination site hot to the touch; Vaccination site tenderness; Product administration error; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Vaccination site hot to the touch), VACCINATION SITE PAIN (Vaccination site tenderness), PRODUCT ADMINISTRATION ERROR (Product administration error), VACCINATION SITE WARMTH (Vaccination site warm) and VACCINATION SITE REACTION (Vaccination site raised 4-5 inches in diameter) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-May-2021, the patient experienced VACCINATION SITE WARMTH (Vaccination site hot to the touch), VACCINATION SITE PAIN (Vaccination site tenderness), PRODUCT ADMINISTRATION ERROR (Product administration error), VACCINATION SITE REACTION (Vaccination site raised 4-5 inches in diameter), INJECTION SITE ERYTHEMA (Injection site redness 4-5 inches in diameter /Injection site Bright pink/ red in color) and INJECTION SITE SWELLING (Injection site swelling 4-5 inches in diameter). On 04-Jun-2021, the patient experienced VACCINATION SITE WARMTH (Vaccination site warm), VACCINATION SITE PRURITUS (Vaccination site itching 2-3 inches in diameter) and VACCINATION SITE SWELLING (Vaccination site swollen 2-3 inches in diameter). At the time of the report, VACCINATION SITE WARMTH (Vaccination site hot to the touch), VACCINATION SITE PAIN (Vaccination site tenderness), PRODUCT ADMINISTRATION ERROR (Product administration error), VACCINATION SITE WARMTH (Vaccination site warm), VACCINATION SITE REACTION (Vaccination site raised 4-5 inches in diameter), VACCINATION SITE PRURITUS (Vaccination site itching 2-3 inches in diameter), INJECTION SITE ERYTHEMA (Injection site redness 4-5 inches in diameter /Injection site Bright pink/ red in color), INJECTION SITE SWELLING (Injection site swelling 4-5 inches in diameter) and VACCINATION SITE SWELLING (Vaccination site swollen 2-3 inches in diameter) outcome was unknown.            Action taken with mRNA-1273 in response to the event were not applicable. Treatment information was not provided Concomitant medication were not provided.
Sex: U
Vaccine: COVID19
Symptoms: Nasopharyngitis, Pyrexia, Tremor, Vomiting
Clinical narrative: cold; shaking; fever; vomiting; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold), TREMOR (shaking), PYREXIA (fever) and VOMITING (vomiting) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (cold), TREMOR (shaking), PYREXIA (fever) and VOMITING (vomiting). At the time of the report, NASOPHARYNGITIS (cold), TREMOR (shaking), PYREXIA (fever) and VOMITING (vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain, Paraesthesia, Swelling, Vitreous floaters
Clinical narrative: eye floaters; toes are tingling; Swollen legs and arms; throbbing pain; body is in pain from neck to toe; This spontaneous case was reported by a consumer and describes the occurrence of VITREOUS FLOATERS (eye floaters), PARAESTHESIA (toes are tingling), SWELLING (Swollen legs and arms), PAIN (throbbing pain) and MYALGIA (body is in pain from neck to toe) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VITREOUS FLOATERS (eye floaters), PARAESTHESIA (toes are tingling), SWELLING (Swollen legs and arms), PAIN (throbbing pain) and MYALGIA (body is in pain from neck to toe). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. At the time of the report, VITREOUS FLOATERS (eye floaters), PARAESTHESIA (toes are tingling), SWELLING (Swollen legs and arms), PAIN (throbbing pain) and MYALGIA (body is in pain from neck to toe) outcome was unknown.            No concomitant medications were reported.  Action taken with mRNA-1273 in response to the events was not Applicable.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Arthritis, X-ray
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of arthralgia (severe pain in her left knee/pain somewhat relieved) and arthritis (developing arthritis) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On May 6, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On May 14, 2021, patient experienced arthralgia (severe pain in her left knee/pain somewhat relieved). On May 18, 2021, patient experienced arthritis (developing arthritis). The patient treated with Naproxen sodium for arthritis, at an unspecified dose and frequency. At the time of the report, arthralgia (severe pain in her left knee/pain somewhat relieved) had resolved and arthritis (developing arthritis) outcome: unknown. Diagnostic results: On an unknown date, X-ray: developing arthritis. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant product use reported. Treatment also included steroid shot in knee and anti-inflammatory medications.
Sex: U
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: I got sick from it; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (I got sick from it) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (I got sick from it). At the time of the report, ILLNESS (I got sick from it) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Relevant concomitant medications was reported.  Treatment information was not provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Anosmia, Illness, Neck pain
Clinical narrative: lost her sense of smell again; got sick,stayed in bed rest of Saturday and Sunday; some pain in lower back right side neck area; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (got sick,stayed in bed rest of Saturday and Sunday), NECK PAIN (some pain in lower back right side neck area) and ANOSMIA (lost her sense of smell again) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in March 2020. Concomitant products included ZINC, VITAMIN D [VITAMIN D NOS] and ASCORBIC ACID (VIT C) for an unknown indication.    On 15-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-May-2021, the patient experienced ILLNESS (got sick,stayed in bed rest of Saturday and Sunday) and NECK PAIN (some pain in lower back right side neck area). On an unknown date, the patient experienced ANOSMIA (lost her sense of smell again). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, ILLNESS (got sick,stayed in bed rest of Saturday and Sunday), NECK PAIN (some pain in lower back right side neck area) and ANOSMIA (lost her sense of smell again) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004C21A and 042B21-2A) for COVID-19 vaccination.     Concurrent medical conditions included Acute myeloid leukemia (started clinical trial drug in February 2021) since 2013. Concomitant products included AMLODIPINE from 2013 to an unknown date for Blood pressure management, VALACYCLOVIR [VALACICLOVIR] from 2013 to an unknown date and SULFAMETHOXAZOLE, TRIMETHOPRIM (BACTRIM) from 2013 to an unknown date for Cancer, FLUCONAZOLE from 2013 to an unknown date for Pneumonia fungal.   On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Jun-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 03-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant products used included Belumosudil 200mg bid as clinical trial drug since ??-Feb-2021,No treatment medication was provided.  Action taken with mRNA-1273 in response to the event was not applicable.  The patient received both doses in deltoid. Capped vaccine was kept refrigerated according to storage guidelines of between 36-46 degrees F and was only uncapped and removed from refrigeration prior to vaccination.   This case was linked to MOD-2021-215651 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2021: Added patient demographics, added medical history and concomitant medications, Added first dose details, updated event description, added event stop date and outcome.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Body temperature, Chills, Fatigue, Hyperhidrosis
Clinical narrative: Sweating; Patient had an upset stomach; Sore left arm / muscle pain; Chills; Fatigue; Fever; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), ABDOMINAL DISCOMFORT (Patient had an upset stomach), MYALGIA (Sore left arm / muscle pain), CHILLS (Chills) and FATIGUE (Fatigue) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Decreased immune responsiveness (Patient had a compromised immune system prior to vaccine administration). Concomitant products included ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE (TRIUMEQ) for an unknown indication.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced HYPERHIDROSIS (Sweating), ABDOMINAL DISCOMFORT (Patient had an upset stomach), MYALGIA (Sore left arm / muscle pain), CHILLS (Chills) and FATIGUE (Fatigue). 08-Apr-2021, the patient experienced PYREXIA (Fever). On 10-Apr-2021, HYPERHIDROSIS (Sweating), ABDOMINAL DISCOMFORT (Patient had an upset stomach), MYALGIA (Sore left arm / muscle pain), CHILLS (Chills), FATIGUE (Fatigue) and PYREXIA (Fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, Body temperature: 101.2 (High) Reported as 101.2.         Treatment information was not provided.   Action taken with mRNA-1273 in response to the events were not applicable.   This case was linked to MOD-2021-064238 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Follow-up information received on 04-jun-2021 contains No significant information. the patients ridged crescent has  moved approximately way up to nail in the 2 months since the second dose.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Sweating; Patient had an upset stomach; Sore left arm / muscle pain; Chills; Fatigue; Fever; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), ABDOMINAL DISCOMFORT (Patient had an upset stomach), MYALGIA (Sore left arm / muscle pain), CHILLS (Chills) and FATIGUE (Fatigue) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Decreased immune responsiveness (Patient had a compromised immune system prior to vaccine administration). Concomitant products included ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE (TRIUMEQ) for an unknown indication.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced HYPERHIDROSIS (Sweating), ABDOMINAL DISCOMFORT (Patient had an upset stomach), MYALGIA (Sore left arm / muscle pain), CHILLS (Chills) and FATIGUE (Fatigue). 08-Apr-2021, the patient experienced PYREXIA (Fever). On 10-Apr-2021, HYPERHIDROSIS (Sweating), ABDOMINAL DISCOMFORT (Patient had an upset stomach), MYALGIA (Sore left arm / muscle pain), CHILLS (Chills), FATIGUE (Fatigue) and PYREXIA (Fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, Body temperature: 101.2 (High) Reported as 101.2.         Treatment information was not provided.   Action taken with mRNA-1273 in response to the events were not applicable.   This case was linked to MOD-2021-064238 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Follow-up information received on 04-jun-2021 contains No significant information. the patients ridged crescent has  moved approximately way up to nail in the 2 months since the second dose.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Crying
Clinical narrative: Crying; Chills; This spontaneous case was reported by a consumer and describes the occurrence of CRYING (Crying) and CHILLS (Chills) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CRYING (Crying) and CHILLS (Chills). At the time of the report, CRYING (Crying) and CHILLS (Chills) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was reported. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, X-ray
Clinical narrative: Right foot swollen up; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PERIPHERAL SWELLING (Right foot swollen up) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced PERIPHERAL SWELLING (Right foot swollen up). At the time of the report, PERIPHERAL SWELLING (Right foot swollen up) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, X-ray: inconclusive (Inconclusive) Results were not reported..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient was not having any concomitant medication at the time of report. Treatment information was not provided.  The patient had consulted an orthopedic surgeon and had scheduled an appointment with cardiologist.   This case was linked to MOD-2021-209275.
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Vaccination site pain
Clinical narrative: Flu like symptoms; Pain under arm of same injection site; This spontaneous case was reported by a pharmacist and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) and VACCINATION SITE PAIN (Pain under arm of same injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms) and VACCINATION SITE PAIN (Pain under arm of same injection site). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) and VACCINATION SITE PAIN (Pain under arm of same injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was reported No treatment information was provided
Sex: M
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Myalgia, Pyrexia
Clinical narrative: Watery diarrhea; chills; fatigue; body aches; fever; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Watery diarrhea), CHILLS (chills), FATIGUE (fatigue), MYALGIA (body aches) and PYREXIA (fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033C21A and 047B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Watery diarrhea), CHILLS (chills), FATIGUE (fatigue), MYALGIA (body aches) and PYREXIA (fever). At the time of the report, DIARRHOEA (Watery diarrhea), CHILLS (chills), FATIGUE (fatigue), MYALGIA (body aches) and PYREXIA (fever) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.  No Relevant concomitant medications was reported.  Treatment information included drinking fluids.
Sex: U
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Can I take a painkiller?; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Can I take a painkiller?) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Can I take a painkiller?). At the time of the report, MYALGIA (Can I take a painkiller?) outcome was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills
Clinical narrative: Feeling a bit weak; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Feeling a bit weak) and CHILLS (Chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Jun-2021, the patient experienced ASTHENIA (Feeling a bit weak) and CHILLS (Chills). At the time of the report, ASTHENIA (Feeling a bit weak) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment details were reported.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, Vaccination complication
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (many side effects) and PRODUCT DOSE OMISSION ISSUE (I never did my second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. In December 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (many side effects) and PRODUCT DOSE OMISSION ISSUE (I never did my second dose). At the time of the report, VACCINATION COMPLICATION (many side effects) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (I never did my second dose) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided by the reporter. Treatment information was not provided.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, SARS-CoV-2 antibody test negative
Clinical narrative: soreness in arm; This spontaneous case was reported by a physician and describes the occurrence of MYALGIA (soreness in arm) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011520A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (soreness in arm). At the time of the report, MYALGIA (soreness in arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Jun-2021, SARS-CoV-2 antibody test negative: noraml Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitant medications reported. no treatment details reported.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: rash at injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE RASH (rash at injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (rash at injection site). At the time of the report, VACCINATION SITE RASH (rash at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. Treatment medication was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Nasal congestion, Sinusitis, Sneezing
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of nasal congestion (lot of congestion and excessive mucous), sinusitis (sinus infection) and sneezing in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced nasal congestion (lot of congestion and excessive mucous), sinusitis (sinus infection) and sneezing. At the time of the report, nasal congestion (lot of congestion and excessive mucous), sinusitis (sinus infection) and sneezing outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medications reported. Treatment included 3 rounds of antibiotics.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Product dose omission issue, Vaccination complication
Clinical narrative: 37 days since first dose/Didn't take the second dose because I wasn't feeling well when I was scheduled to take it; Didn't receive her second dose in May because she wasn't feeling well; Sick with congestion (coughed); This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (37 days since first dose/Didn't take the second dose because I wasn't feeling well when I was scheduled to take it), VACCINATION COMPLICATION (Didn't receive her second dose in May because she wasn't feeling well) and COUGH (Sick with congestion (coughed)) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma. Concomitant products included SALBUTAMOL (ALBUTEROL HFA), FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) and MONTELUKAST for Asthma.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (37 days since first dose/Didn't take the second dose because I wasn't feeling well when I was scheduled to take it), VACCINATION COMPLICATION (Didn't receive her second dose in May because she wasn't feeling well) and COUGH (Sick with congestion (coughed)). At the time of the report, PRODUCT DOSE OMISSION ISSUE (37 days since first dose/Didn't take the second dose because I wasn't feeling well when I was scheduled to take it), VACCINATION COMPLICATION (Didn't receive her second dose in May because she wasn't feeling well) and COUGH (Sick with congestion (coughed)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  Treatment medications was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: second shot is not administered with 35days interval/Second shot was not administered/it's been five months; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (second shot is not administered with 35days interval/Second shot was not administered/it's been five months) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (second shot is not administered with 35days interval/Second shot was not administered/it's been five months). At the time of the report, PRODUCT DOSE OMISSION ISSUE (second shot is not administered with 35days interval/Second shot was not administered/it's been five months) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product use was reported No treatment information was provided   Reporter did not allow further contact